Clinical Trial: Effect of Omega-3 Supplementation on Pregnant Outcomes and Inflammation Markers of Women Infected With HIV Using Antiretroviral Therapy

U.S., May 15 -- ClinicalTrials.gov registry received information related to the study (NCT06971445) titled 'Effect of Omega-3 Supplementation on Pregnant Outcomes and Inflammation Markers of Women Infected With HIV Using Antiretroviral Therapy' on May 06.

Brief Summary: The goal of this clinical trial is to determine the effect of PUFA-n3 supplementation on birth weight, length of gestation, and plasma inflammatory markers in pregnant women with HIV+ who are on antiretroviral therapy. The main questions it aims to answer are:

Will the neonates of women with HIV who received supplementation with 1280 mg of PUFA-n3 during pregnancy have higher birth weight and a longer gestation than the neonates of women with HIV who received a placebo? Wi...